Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
◆ Single digit premiums offered ◆ Reverse Yankees dominating euro supply ◆ Floaters proving popular with multi-tranche issuers
More articles/Ad
More articles/Ad
More articles
-
Ninety One, the asset management division of Investec, has set a price range for its IPO on the London Stock Exchange, despite extreme market turbulence caused by the spread of the Covid-19 coronavirus across the globe. -
Ghana Cocoa Board's latest entry into international capital markets has been faced with delays as a result of coronavirus, according to bankers. The deal, which was meant to close at the end of January, will now likely close within a few weeks.
-
The Asian Infrastructure Investment Bank, the Beijing-based supranational, has had to adapt fast to prevent its lending and funding operations being disrupted by the spread of the Covid-19.
-
In this round-up, China’s Purchasing Managers’ Index (PMI) dropped to record lows in February, the Hainan provincial government has stepped in to restructure HNA Group and the updated Securities Law took effect on Sunday.
-
Dubai Islamic Bank, which began roadshows over a week ago for a senior unsecured sukuk, has postponed the deal as a result of the Covid-19 virus, according to bankers near the deal. The spread of the virus has caused sharp swings in global markets, causing havoc in primary markets.
-
Chinese biotechnology company InnoCare Pharma has won final approval for its Hong Kong IPO. The next step is marketing the deal, after delayed investor meetings in February.
